Dr. Park Taps Thermo Fisher to Provide Bioreactors & Consumables for New Facility

Dr. Park, an emerging viral vector contract development and manufacturing organization (CDMO) based in South Korea, has selected Thermo Fisher Scientific Inc. to provide advanced bioreactors and consumables for its newest facility.

Dr. Park specializes in Adeno-associated virus-based (AAV-based) viral vector production. The company’s new Phase 1 facility, which was inaugurated on August 5, 2025, is designed to achieve cGMP certification in 2026 and expand access to cell and gene therapies globally. Plans are also in place to further increase capacity to 10,000 L per batch in the future.

To support these ambitions, the new facility has integrated and set up several solutions from Thermo Fisher’s portfolio, including:

• Thermo Fisher Scientific HyPerforma 1,000 L Single-Use Bioreactor
• Thermo Scientific Nunc Automated Cell Factory Manipulator
• Thermo Scientific DynaSpin Single-Use Centrifuge

These technologies are designed to streamline upstream and downstream processes, reduce manual interventions and support rapid scale-up from clinical to commercial production. By improving process control and automation, these solutions will help enhance efficiency, scalability and consistency throughout the manufacturing process, helping meet growing demand for therapeutics while maintaining high standards of quality, safety and regulatory compliance.

“We are proud to collaborate with Dr. Park CDMO as they advance viral vector manufacturing in South Korea,” said Daniella Cramp, Senior Vice President and President, BioProduction at Thermo Fisher Scientific. “By providing our reliable and scalable bioprocessing solutions, we aim to speed up development and delivery of cell and gene therapies to patients who need them.”

“Our collaboration with Thermo Fisher Scientific has been instrumental in equipping our new facility with advanced bioproduction capabilities,” said Yong-Ho Park, CEO, Dr. Park. “Their cutting-edge technologies and deep expertise are critical enablers of our long-term vision and will strengthen our ability to serve customers globally.”